Michelle Renee Griffin - Mar 27, 2023 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role: Director
Signature: /s/ Michelle Renee Griffin by Stacy L Taylor, Attorney-in-Fact
Stock symbol: ADPT
Transactions as of: Mar 27, 2023
Transactions value $: -$19,878
Form type: 4
Date filed: 3/29/2023, 05:01 PM
Previous filing: Mar 16, 2023
Next filing: May 31, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADPT	Common Stock	Sale	-$19.9K	-2.34K	-10.19%	$8.49	20.6K	Mar 27, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
F2	The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.41 to $8.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

Content

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.

The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.41 to $8.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.